2020 annual financial data
Bolt Biotherapeutics 2020 Operating margin
Direct answer
Operating margin was -21,290.91%.
Operating income was -49,182,000 USD and net income was -60,728,000 USD.
Operating cash flow was -47,308,000 USD.
Get free Bolt Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 231,000 USD
- Operating income
- -49,182,000 USD
- Net income
- -60,728,000 USD
- Operating cash flow
- -47,308,000 USD